Skip to content

A Comparison of the Laryngeal Mask Airway (LMA) Supreme and I-gel in Children

A Randomized Trial Comparing the Laryngeal Mask Airway-SupremeTM With the i-gelTM in Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01633073
Enrollment
170
Registered
2012-07-04
Start date
2012-06-30
Completion date
2012-09-30
Last updated
2012-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laryngeal Masks in Children

Brief summary

The aim of this randomized prospective study is to compare two single-use laryngeal mask airways with a provision of a gastric drain tube allowing for evacuation of gastric contents, the i-gel and the LMA Supreme, in pediatric patients undergoing positive pressure ventilation. The investigators hypothesize that airway leak pressures with the i-gel will not be significantly different clinically (higher) when compared with the LMA Supreme.

Detailed description

The goal of this study is to compare the LMA Supreme and i-gel in children having surgery. The investigators hypothesize that airway leak pressures with the i-gel will not be significantly different clinically (higher) when compared with the LMA Supreme. Airway leak pressures will be measured by recording the circuit pressure at which equilibrium is reached. The ease of placement, fiberoptic grade of laryngeal view, feasibility of use during positive pressure ventilation, ease of gastric tube placement, and complications (airway related, gastric insufflation, and trauma) will also be assessed.

Interventions

DEVICELMA Supreme: control device

LMA Supreme will be placed in children weighing 5-50kg based on a computer generated randomization. One of four different sizes of airways will be used: 1.5, 2.0, 2.5, or 3.0. The size of the airway device will be determined according to the manufacturer's guidelines that are standardized by the patient's weight in kilograms.

DEVICEi-gel: comparison device

i-gel will be placed in children weighing 5-50kg based on a computer generated randomization. One of four different sizes of airways will be used: 1.5, 2.0, 2.5, or 3.0. The size of the airway device will be determined according to the manufacturer's guidelines that are standardized by the patient's weight in kilograms.

Sponsors

Ann & Robert H Lurie Children's Hospital of Chicago
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
3 Months to 11 Years
Healthy volunteers
Yes

Inclusion criteria

* Children undergoing general anesthesia using a supraglottic airway device * weight 5-50 kg * age 3 months-11 years

Exclusion criteria

* ASA class IV, V Emergency procedures * active respiratory infection * known history of difficult mask ventilation * a diagnosis of a congenital syndrome associated with difficult airway management * airway abnormalities (e.g., laryngomalacia, subglottic stenosis) * active gastrointestinal reflux * coagulopathy * clinically significant pulmonary disease(s)

Design outcomes

Primary

MeasureTime frameDescription
Airway Leak PressureParticipants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hoursAirway leak pressures will be measured by recording the circuit pressure at which equilibrium is reached when fresh gas flow is delivered at 3L/min when the pressure limiting valve is closed.

Secondary

MeasureTime frameDescription
Number of attempts to place the deviceParticipants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hoursNumber of attempts needed for successful placement will be recorded (maximum of 3 attempts will be considered as a failure)
Fiberoptic grade of laryngeal viewParticipants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hoursThe laryngeal alignment through the devices will be graded using an established scoring system
Gastric insufflationParticipants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hoursThe presence of gastric insufflations will be assessed during leak pressure testing by using epigastric auscultation
Ease of gastric tube placementParticipants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hoursThe ease of gastric placement will be timed and assessed using a subjective scale
Time to secure the airwayParticipants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hoursFrom picking up the airway device to bilateral chest expansion and presence of ETCO2
Quality of the airwayParticipants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hoursThe quality of hands free anesthesia will be assessed during maintenance of anesthesia using a previously described scale
Incidence of device repositioning and/or replacementParticipants will be followed for the duration of anesthesia and after surgery, an average of 24 hoursIntra-operative device repositioning or replacement of the device due to excessive air leak or airway obstruction, as evidenced by an obstructive pattern on the continuous end-tidal carbon dioxide monitor that leads to a decrease in oxygen saturation by pulse oximetry to less than 90%.
Oropharyngolaryngeal morbidity at dischargeParticipants will be followed for the duration of anesthesia and after surgery, an average of 24 hoursAssessed by the subject's response or parents subjective assesment to standardized questions regarding oropharyngeal complaints such as sore throat, jaw pain, neck discomfort.
Oropharyngolaryngeal morbidity at 24 hours post-operativelyMeasured at 24 hours after device placement/study initiationAssessed by the subject's response or parents subjective assesment to standardized questions regarding oropharyngeal complaints such as sore throat, jaw pain, neck discomfort.
Feasibility of positive pressure ventilationParticipants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hoursPeak inspiratory pressure and tidal volumes will be recorded. Maximum peak inspiratory pressure will be the airway leak pressure was determined for each patient

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026